Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting

The Food and Drug Administration FDA or Agency is announcing an opportunity for public

Agency Information Collection Activities; Proposed Collection; Comment Request; Biosimilars User Fee Program

The Food and Drug Administration FDA or Agency is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

End Stage Renal Disease Annual Facility Survey Form (CMS-2744)

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

AS17-Proposed Rule-Legal Services for Veterans: Legal Assistance for Access to VA Programs Grant Program

The Department of Veterans Affairs VA proposes to amend its regulations to implement a new authority requiring VA to establish a pilot program to assess the feasibility of awarding grants …

Agency Information Collection Activities; Proposed Collection; Comment Request; Promotion of Prescription Drugs Within a Talk Show Format

The Food and Drug Administration FDA Agency or we is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction …

Agency Information Collection Activities; Proposals, Submissions, and Approvals

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Final Peer Review Organizations Sanction and Supporting Regulations (CMS-R-65)

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices

The Food and Drug Administration FDA the Agency or we is proposing to reclassify qualitative hepatitis B virus HBV antigen assays qualitative HBV antibody assays and quantitative assays that detect …

Bid Pricing Tool (BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans (PDP) (CMS-10142)

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Determination of Regulatory Review Period for Purposes of Patent Extension; Wavewriter Alpha Spinal Cord Stimulator System

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for WAVEWRITER ALPHA SPINAL CORD STIMULATOR SYSTEM and is publishing this notice of that determination …

Determination of Regulatory Review Period for Purposes of Patent Extension; EXXUA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for EXXUA and is publishing this notice of that determination as required by law. FDA …

Part D Coordination of Benefits Data (CMS-10171)

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Determination of Regulatory Review Period for Purposes of Patent Extension; Gore Tag Thoracic Branch Endoprosthesis

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for GORE TAG THORACIC BRANCH ENDOPROSTHESIS and is publishing this notice of that determination as …

Determination of Regulatory Review Period for Purposes of Patent Extension; Gore Tag Thoracic Branch Endoprosthesis

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for GORE TAG THORACIC BRANCH ENDOPROSTHESIS and is publishing this notice of that determination as …